526 related articles for article (PubMed ID: 19739673)
1. Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine.
Poirier A; Funk C; Scherrmann JM; Lavé T
Mol Pharm; 2009; 6(6):1716-33. PubMed ID: 19739673
[TBL] [Abstract][Full Text] [Related]
2. Design, data analysis, and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro model.
Poirier A; Lavé T; Portmann R; Brun ME; Senner F; Kansy M; Grimm HP; Funk C
Drug Metab Dispos; 2008 Dec; 36(12):2434-44. PubMed ID: 18809732
[TBL] [Abstract][Full Text] [Related]
3. Prediction of pharmacokinetic profile of valsartan in humans based on in vitro uptake-transport data.
Poirier A; Cascais AC; Funk C; Lavé T
Chem Biodivers; 2009 Nov; 6(11):1975-87. PubMed ID: 19937834
[TBL] [Abstract][Full Text] [Related]
4. Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data.
Poirier A; Cascais AC; Funk C; Lavé T
J Pharmacokinet Pharmacodyn; 2009 Dec; 36(6):585-611. PubMed ID: 19936896
[TBL] [Abstract][Full Text] [Related]
5. Kinetic determinants of hepatic clearance: plasma protein binding and hepatic uptake.
Baker M; Parton T
Xenobiotica; 2007; 37(10-11):1110-34. PubMed ID: 17968739
[TBL] [Abstract][Full Text] [Related]
6. Carrier-mediated hepatic uptake of the cationic cyclopeptide, octreotide, in rats. Comparison between in vivo and in vitro.
Yamada T; Niinuma K; Lemaire M; Terasaki T; Sugiyama Y
Drug Metab Dispos; 1997 May; 25(5):536-43. PubMed ID: 9152591
[TBL] [Abstract][Full Text] [Related]
7. Kinetic study of the hepatobiliary transport of a new prostaglandin receptor agonist.
Imawaka H; Sugiyama Y
J Pharmacol Exp Ther; 1998 Mar; 284(3):949-57. PubMed ID: 9495854
[TBL] [Abstract][Full Text] [Related]
8. Effect of plasma protein binding on in vitro-in vivo correlation of biliary excretion of drugs evaluated by sandwich-cultured rat hepatocytes.
Fukuda H; Ohashi R; Tsuda-Tsukimoto M; Tamai I
Drug Metab Dispos; 2008 Jul; 36(7):1275-82. PubMed ID: 18388177
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics and hepatic disposition of repaglinide in pigs: mechanistic modeling of metabolism and transport.
Sjögren E; Bredberg U; Lennernäs H
Mol Pharm; 2012 Apr; 9(4):823-41. PubMed ID: 22352317
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data.
Jones HM; Barton HA; Lai Y; Bi YA; Kimoto E; Kempshall S; Tate SC; El-Kattan A; Houston JB; Galetin A; Fenner KS
Drug Metab Dispos; 2012 May; 40(5):1007-17. PubMed ID: 22344703
[TBL] [Abstract][Full Text] [Related]
11. Prediction of the hepatic and renal clearance of transporter substrates in rats using in vitro uptake experiments.
Watanabe T; Maeda K; Kondo T; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2009 Jul; 37(7):1471-9. PubMed ID: 19364828
[TBL] [Abstract][Full Text] [Related]
12. Effects of verapamil on the pharmacokinetics and hepatobiliary disposition of fexofenadine in pigs.
Sjögren E; Hedeland M; Bondesson U; Lennernäs H
Eur J Pharm Sci; 2014 Jun; 57():214-23. PubMed ID: 24075962
[TBL] [Abstract][Full Text] [Related]
13. Hepatobiliary disposition of a drug/metabolite pair: Comprehensive pharmacokinetic modeling in sandwich-cultured rat hepatocytes.
Turncliff RZ; Hoffmaster KA; Kalvass JC; Pollack GM; Brouwer KL
J Pharmacol Exp Ther; 2006 Aug; 318(2):881-9. PubMed ID: 16690724
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of biliary excretion of methotrexate by probenecid in rats: quantitative prediction of interaction from in vitro data.
Ueda K; Kato Y; Komatsu K; Sugiyama Y
J Pharmacol Exp Ther; 2001 Jun; 297(3):1036-43. PubMed ID: 11356926
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes.
Paine SW; Parker AJ; Gardiner P; Webborn PJ; Riley RJ
Drug Metab Dispos; 2008 Jul; 36(7):1365-74. PubMed ID: 18426955
[TBL] [Abstract][Full Text] [Related]
16. Kinetic characterization of rat hepatic uptake of 16 actively transported drugs.
Yabe Y; Galetin A; Houston JB
Drug Metab Dispos; 2011 Oct; 39(10):1808-14. PubMed ID: 21730030
[TBL] [Abstract][Full Text] [Related]
17. Prediction of oral pharmacokinetics of cMet kinase inhibitors in humans: physiologically based pharmacokinetic model versus traditional one-compartment model.
Yamazaki S; Skaptason J; Romero D; Vekich S; Jones HM; Tan W; Wilner KD; Koudriakova T
Drug Metab Dispos; 2011 Mar; 39(3):383-93. PubMed ID: 21098644
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of the tissue distribution and biliary excretion of the cyclic peptide octreotide.
Yamada T; Niinuma K; Lemaire M; Terasaki T; Sugiyama Y
J Pharmacol Exp Ther; 1996 Dec; 279(3):1357-64. PubMed ID: 8968360
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein plays a major role in the efflux of fexofenadine in the small intestine and blood-brain barrier, but only a limited role in its biliary excretion.
Tahara H; Kusuhara H; Fuse E; Sugiyama Y
Drug Metab Dispos; 2005 Jul; 33(7):963-8. PubMed ID: 15821041
[TBL] [Abstract][Full Text] [Related]
20. Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs.
De Buck SS; Sinha VK; Fenu LA; Nijsen MJ; Mackie CE; Gilissen RA
Drug Metab Dispos; 2007 Oct; 35(10):1766-80. PubMed ID: 17620347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
